Funding news
Oxford Drug Design logo

Oxford Drug Design Raises $5.0M Series A Funding

Recently funded · $5.0M Series aHospitals and Health CareGBView source

Get the full Oxford Drug Design company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A biotechnology company leveraging pioneering computational methods to develop novel therapeutics, Oxford Drug Design has closed a $5.0M Series A funding round.

The advanced spinout from Oxford University focuses on designing innovative drugs with differentiated modes of action against cancer and other challenging diseases where patient outcomes need significant improvement. Its distinctive drug discovery platform uniquely integrates AI/ML methods with expertise in aminoacyl-tRNA synthetase enzymes, allowing for the rapid discovery of novel therapeutic candidates.

Other United Kingdom companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Netris logo

Netris

United States

$4.7M
2
Finnovate logo

Finnovate

India

$2.0M
3
Luxonis logo

Luxonis

United States

$14.0M
4
? Vinyl logo

? Vinyl

$20.0M
5
VARM logo

VARM

Germany

$18.9M